ESR1 and breast carcinoma: Collectively, our study would indicate the complexity of cell distribution driving the tumour proliferation in ER+ breast cancers, that is, ER‐positive (PNP and PPP/NPP) and ‐negative (NNP) cells, and our findings support the importance of combination therapy to suppress all proliferative populations within a single tumour.